Table 1.

Patient characteristics for discovery and validation cohorts

Disease group	Discovery cohort					Validation cohort
	Living donor	Nephrotic syndrome	ANCA-associated vasculitis	Systemic lupus erythematosus	Tumour nephrectomy	Living donor	Nephrotic syndrome	ANCA-associated vasculitis
Glomerular samples	21	58	23	32	6	6	90	15
Tubulointerstitial samples	21	47	21	32	0	5	107	57
Age, years (SD)	47.3 (11.5)	47.2 (17.7)	58.0 (13.8)	35.1 (13.3)	66.4 (6.8)	52.5 (6.9)	47.1 (15.7)	57.8 (9.8)
Sex (% female)	45	45	43	78	100	57	33	58
Glomerular filtration rate (SD)	104 (31)	83 (39)	46 (31)	64 (39)	58 (10.5)	108 (33)	77 (32)	31 (27)

ANCA, antineutrophil cytoplasmic antibody.